ABSTRACT
INTRODUCTION
Pooling involves mixing together RNA from several biological specimens before labelling and hybridization. Investigators may wish to pool samples because there is not enough RNA available from each individual sample to hybridize with an array or because they want to reduce the number of arrays for the purpose of saving cost. In order to understand the implication of pooling on the estimation of the true mean gene expression in the population of interest and the impact on the statistical power in detecting differential expression between pre-defined classes, one has to begin with considering different sources of variation arising in microarray experiments Simon, 2002, Kendziorski et al, 2003) . These variations can be generally classified into three categories: array variation, non-array-technical variation and biological variation. Array variation comes from measurement error associated with the array process. When RNA from a given specimen is arrayed repeatedly, gene expression measurements observed from each array fluctuate around the true expression for that specimen and differences between the observed and true expression are likely due to variations in array printing, RNA fluoresence labelling and purification, hybridization or scanning. Non-array-technical variation comes from variation in the preparation of RNA prior to the array process. Sources of non-array-technical variation include tissue handling and RNA extraction. For example, for a given tumor, different ways of tissue cutting may extract different types of cells which could result in different levels of gene expression. The third category, biological variation, represents variability among subjects in the population under study. Except for quality control purposes where one may be interested in performing a few repeated arrays using the same RNA or different RNA extractions to assess reproducibility, generally the goal of microarray experiments is to make inferences about the population of interest. To achieve this goal, one has to sample multiple subjects from each population under study, because repeated arrays of the same RNA or multiple arrays of different RNA of the same subject only allows one to infer to the specific RNA or specimen. In the context of pooling, a single pool of possibly many specimens does not allow for the estimation of either biological or technical variability. Taking multiple aliquots from a single pool and applying each aliquot to an array does not include biological variation and only allows one to estimate the array variability from the multiple aliquots, and in turn one can only make inferences about those specific specimens in the pool. Unless the pool is constructed from a large set of biological specimens representing the population, repeated arrays of multiple aliquots from the same pool do not provide adequate replications in drawing inference. In order to make an appropriate inference to the population, one needs to generate multiple pools from different sets of individual samples so that the sets of pooled samples are independent and represent biological replication.
Throughout the paper, our assumption is that one is interested in making inference to the population under study, and therefore, a design with replicate arrays using the same individual RNA sample or pooled RNA sample is dropped from consideration. Also we limit our consideration to array variation and biological variation to study the effects of pooling.
The reader is referred to Dobbin et al. (2003) for details about the loss of efficiency and power in class comparison when the total number of arrays is fixed and repeated arrays are run for each RNA sample.
Recently Kendziorski et al. (2003) studied the efficiency of pooling mRNA samples in microarray experiments. They derive formulae for the total number of subjects and arrays required in a pooled experiment to obtain gene expression estimates and confidence intervals comparable to those obtained from a non-pooled experiment. They show that in certain situations by pooling an increased number of specimens one can reduce the number of arrays without a loss of precision. However their formulas for calculating the required number of subjects for a pooled design to achieve the same efficiency as a non-pooled design can not be used to determine the number of subjects to achieve a desired power in detecting differential gene expression between two classes. Peng et al. (2003) study the implication of pooling on the power in detecting differential gene expression, but the different sources of variation in microarray experiment were not distinguished. Because pooling reduces only the biological variation exhibited in each array, not array variation, a pooled design without separating these two types of variation would result in a smaller estimate of the variance for the expression measurement which leads to a smaller estimate of the number of different pools, and consequently yields a lower statistical power than targeted. Herein, we study the implication of pooling in detecting differential gene expression incorporating different sources of variation. We present formulas for the required number of subjects and arrays to achieve a desired power comparable to that of a non-pooled experiment. We also check the adequacy of the model assumption of pooling using real data from both cDNA and Affymetrix GeneChip microarray experiments.
METHODS

Sample size calculation for non-pooled design
We consider a simple sample size calculation for two-group class comparisons using singlechannel arrays or dual-label arrays with the common reference design. For the purpose of convenience of presentation, we drop the notation for gene, and consider a single gene. For simplicity, we assume samples come from two classes. Let X ij , i = 1, · · · , n j , j = 1, 2 denote the observed expression measurement of subject i in class j which has been appropriately pre-processed, normalized and possibly transformed. Assume that X ij follows an additive model,
where µ j is the average gene expression of class j, η ij and ij are biological and array measurement errors respectively, which are independent and normally distributed with mean 0 and variance τ 2 and σ 2 respectively. A similar but more complicated model has been considered by Dobbin and Simon (2002) in comparing the efficiency of different designs of cDNA dual-channel microarray experiments. Kendziorski et. al (2003) use the above model to study the efficiency of pooling mRNA in microarray experiments. The total variance associated with X ij is equal to τ 2 + σ 2 . Under a non-pooled design where RNA from an individual sample is probed by an array, the number of arrays n a is equal to the number of subjects, n s = n 1 + n 2 . The best linear unbiased estimator of µ 1 − µ 2 is the sample mean difference,X 1 −X 2 , whereX j = i X ij /n j , j = 1, 2. The associated variance is (τ 2 +σ 2 )(1/n 1 +1/n 2 ), where τ 2 +σ 2 can be estimated by
. Note that unless repeated arrays are done for individual RNA samples, τ 2 and σ 2 can not be estimated separately. Under the normality assumption, the null hypothesis of µ 1 = µ 2 is rejected if the absolute value of the t-statistic
exceeds the critical value t(α/2, n 1 + n 2 − 2) at the α significance level, where t(p, m)
is the (1 − p) × 100th percentile of the t−distribution with m degrees of freedom. In order to detect the difference in expression between the two classes using a t-test with an appropriate power, when in fact there is a difference, one needs to plan for a study with an adequate number of independent biological subjects. For a given gene, the minimal total number of arrays (different subjects) required for a non-pooled study to achieve 1 − β power in detecting differential expression satisfies the following equation (Dupont et al., 1990 )
An iterative computational procedure is used to solve the above equation for the total sample size n s . The above formula requires specification of the parameters α, β, δ, total variance τ 2 + σ 2 and q. The parameter q is the proportion of subjects allocated to the first class. The specification of α and β determines the average level of false positive and false negative. Since in microarray studies gene expression levels for thousands of genes will be examined, the value set for α should be small to control for the number of false positives. Common choices for α and β in the analysis of microarray gene expression data are .001 and .05 respectively. Thus if 10, 000 non-differentially expressed genes are examined, the average number of false discoveries will be 10, 000 × .001 = 10 or less. If 100 genes are truly differentially expressed, then the average number of false negative will be 100 × .05 = 5. The parameter δ sets the minimal mean difference of gene expression that is biologically meaningful to be detected. For example, with base 2 logarithms, δ is often set at 1, corresponding to a two-fold geometric mean difference. The total within-class variability, specified through the sum of biological variance and array variance, τ 2 + σ 2 , varies with the gene examined and type of the subjects under study. For example, the total variability for expression levels within each class of inbred strains of mice or cell lines is usually small whereas it is larger for human subjects. The above formula indicates that a larger within-class total variance requires a larger number of subjects to achieve the same power as achieved in the presence of a smaller variance, and a larger number of subjects allows one to detect a smaller fold mean difference. When the number of biological specimens is limited, one is interested in knowing the statistical power one is able to achieve for detecting a certain mean fold difference in gene expression between the two classes. In this case, the approximate formula for calculating the power is given by (Dupont et al., 1990 )
where P m denotes the cumulative probability for a t-distribution with m degrees of freedom.
Since for a fixed value of m, P m (x) is an increasing function of x, power decreases with increasing within-class variability.
Sample size calculation for pooled-design
For a pooled design, RNAs from a few independent subjects are first pooled together and then probed by microarray. In order to assess the between-class difference in average expression, different sets of pools each from different individuals are required to allow one to estimate the within-class variability. Let X * ij , i = 1, · · · , n p,j , j = 1, 2, denote the expression measurement for pool i in class j, and r denote the number of subjects per pool (pool size). Here the total number of independent pools, n p , equals the total number of arrays, n p = n p1 + n p2 = n a . Under the assumption that the gene expression in a pool equals the average expression of the individual samples in that pool, then following (1) X * ij can be represented by
whereη ij denotes the biological error averaged over r subjects in pool i of class j (Kendziorski et al., 2003) . If we further assume that each individual sample in the pool contributes equally to the mixing, then the variance ofη ij is equal to τ 2 /r. Since the array measurement error ij reflects the array-to-array variability, its variance is not affected by pooling and remains the same as in the non-pooled design. Then the mean difference µ 1 − µ 2 can be estimated byX if the absolute value of the t−statisticX * 1 −X * 2 (τ 2 /r + σ 2 )(1/n p1 + 1/n p2 ) exceeds t(α/2, n p −2). Following (2), for fixed r, the total number of different pools required to reject the null hypothesis with 1 − β power is given by
where λ = τ 2 /σ 2 and ν 2 = τ 2 + σ 2 . Note that compared to the non-pooled design, here the within-class variability is reduced by τ 2 (r − 1)/r thus requiring a smaller number of arrays, but in the mean time the degrees of freedom are reduced from n s − 2 to n p − 2 yielding larger values of the t−distribution quantiles, which in turn requires a larger number of arrays. The above formula is useful to determine the number of pools when the number of subjects per pool is constant and fixed. In order to maintain the same power as in the non-pooled design but possibly reduce the number of arrays (number of pools) to a fixed n p , from (5) one needs to set the number of subjects per pool according to the following
where
For example, with (α, β, ν 2 , δ, q, n p ) = (.001, .05, .0625, 1, .5, 10), A = .0525 and the total number of subjects after rounding = 15.
It can be shown that for n p ≤ n s that satisfies (2) for the non-pooled design, r decreases with the ratio of biological to array variance λ. Thus the larger the variance ratio (λ) is, the smaller the number of subjects is required to achieve a power comparable to that for the non-pooled design. The variance ratio is important in studying various designs issues for microarray experiments, including the efficiency of cDNA dual-channel designs (Dobbin and Simon, 2002) , dye bias (Dobbin et al., 2003a) , replications of the RNA samples (Dobbin et al., 2003b) , and efficiency of pooling (Kendziorski et al., 2003) . Note that if n p is small (e.g. < 6), then the reduced degrees of freedom can result in a large increase of the critical value t(α/2, n p − 2) such that either r has to be extremely large or become negative to satisfy equation (6). Kendziorski et al. (2003) derive the number of subjects required for a pooled design to have the same expectation (formula 2.4) or variance (formula 3.1)
of the squared length of the confidence interval of the mean expression measurement as that for a non-pooled design. They show that the number of subjects directly depends on the ratio of biological to array variability. Note that our formulas and theirs are different because they are used to answer different questions: our formulas calculate the number of subjects (or number of pools) required to achieve a desired power at a specified significance level in detecting differential expression between two pre-specified classes, whereas theirs aim at achieving the same efficiency of the average expression for the pooled design as the non-pooled design. More specifically, our formulas involve both the significance level and power, whereas theirs only involve the significance level. In the next section, we present the number of subjects according to (6) and their (3.1).
Comparisons
We consider two scenarios to compare the number of subjects and number of arrays in the non-pooled and pooled designs. The first scenario assumes τ 2 + σ 2 = .25 2 = .0625 which is close to the median variance across genes in some mice microarray studies we have been involved in (Desai et al, 2002) . Under this scenario, with at least two-fold mean difference in expression and equal allocation of biological subjects in each class, for a non-pooled design, a total of 11 arrays (n a = n s = 11) is required to achieve 95% power at the .001 significance level. The lower bound of the total number of subjects obtained from (6) to achieve the comparable power for the pooled design is calculated with respect to different number of pools (n p = 6, 8, 10, 11) and λ (λ = 1, 2, 4, 8). The variance ratio λ measures the relative precision of the microarray experiment. Our experience with microarray studies suggests that for a good quality array experiment, the median of λ's over the genes examined is greater than 3 for dual-channel cDNA arrays using the reference designs and greater than 6 for the single-channel Affymetrix microarrays. It should be noted that the variance ratio from the Affymetrix platform being about twice as much as that from the cDNA platform does not mean that Affymetrix expression measurements have higher precision but reflects the fact that the array variability comes from a single channel for Affymetrix but from two channels for the cDNA arrays, and thus the array variance using Affymetrix is half as much as that using cDNA dual-channel platform. The results are presented in the top portion of Table 1 . When λ = 1, one can only reduce the number of arrays to 9, because further reduction would either be not possible ("-" in Table 1 indicates that no positive value of r can satisfy equation (6)) or require a huge increase of the number of subjects.
When λ is increased to 2, one can reduce the number of arrays to 8 with about 3 times as many subjects as for the non-pooled design. When λ is increased to 4, one can reduce the number of arrays to 7 with more than 3 times as many subjects as for the non-pooled design. Finally when λ = 8, the number of arrays can be reduced to 6 but the number of subjects has to be increased to about 5 times as many as for the non-pooled design.
The numbers of subjects calculated from (3.1) of Kendziorski et al. (2003) at the .05 significance level are also presented in Table 1 . The two sets of numbers are close when the number of pools (n p ) are close to the number of arrays in the non-pooled design (n a ), but generally are different, otherwise.
[Insert Table 1 about here]
When the pooled design is necessary because of insufficient RNA from each individual sample to run an array, one needs to fix the pool size r (number of subjects per pool) and estimate the number of different pools, n p , to achieve the targeted power. Continue the first scenario and calculate n p from (5). The left panel of Table 2 lists the total number of different pools required to achieve 95% power with respect to different pool size (r = 2, 3, 5, 10) and variance ratio (λ = 1, 2, 4, 8). For example, when r = 3, the total number of different pools is 9, 9, 8, 8 for λ = 1, 2, 4 and 8 respectively. Here the effect of λ on the total number of pools is very minimal, as the number of pools is only reduced by 1 when λ is increased from 1 to 8. Also there are few reductions in the number of pools even when r is increased to 10: the required number of pools is 9, 8, 7, 6 for λ = 1, 2, 4, 8 respectively. Therefore, when one needs to pool samples for the reason of insufficient individual RNA and the number of pools is small such as considered in this scenario, one should pool a minimal number of samples such that the mixed RNA is sufficient to run an array, because the cost of the extra samples used is not worth the minimal gains in power.
The second scenario assumes τ 2 + σ 2 = .5 2 = .25 which is more appropriate for expression level of more heterogeneous subjects such as human tumor specimens. Under this second scenario, also with at least 2-fold true mean difference and equal allocation of subjects in each class, a total of 30 subjects (n a = n s = 30) are required to achieve 95% power at .001 significance level for the non-pooled experiment. The results are presented in the lower portion of Table 1 . When λ = 2, one can reduce the number of arrays to 20
by increasing the number of subjects to 46. But to reduce the number of arrays to 14, the number of subjects has to be increased by more than 7 times than in the non-pooled design. Further reduction of number of arrays is not possible to achieve the targeted power.
When λ = 4, to reduce the number of arrays to 20, 38 subjects are required, whereas 64 subjects are required to further reduce the number of arrays to 14. Similar to the first scenario, the calculations according to (6) and (3.1)of Kendziorski et al. (2003) in general yield different numbers of subjects. The right panel of Table 2 lists the required number of pools with the number of samples per pool (r) fixed. It shows that if the study performs a large number of arrays (> 20) , increasing the pool size may help reducing the number of pools. For example, when λ = 4, with 3 subjects per pool 17 arrays are required and with 5 subjects per pool 3 less pools are required.
[Insert Table 2 about here]
These two scenarios show that the benefit of pooling depends not only the ratio of the biological to array variation but also on the degrees of freedom. If the number of independent pools is small, then a large increase of number of subjects is required or sometimes not sufficient to compensate for the loss of degrees of freedom. On the other hand, if the number of independent pools is large, then pooling can be beneficial in achieving the comparable power without an excessive increase in the number of subjects, if the array variability is small relative to the biological variability.
DATA
We examine the model assumption of pooling using data collected from two microarray experiments. The first experiment generated gene expression from 8 arrays using the cDNA platform, 5 of which used RNA from individual normal virgin 12 week old FVB/N female mouse mammary samples and the rest of which were repeated arrays of the pooled RNA equally contributed from the 5 individual samples. RNA was extracted from tissue samples using the TRIzolR extraction reagent (Invitrogen, MD) and RNA integrity was determined by gel electrophoresis or analysis using the Lab-on-a-Chip Bioanalyzer (Agilent, CA). Aliquots of the universal mouse reference RNA (Stratagene, CA) were tagged with dye Cy3 in all these 8 arrays, and the individual as well as the pooled RNA samples were tagged with dye Cy5, and competitively hybridized using the cDNA Incyte mouse
GEM2 microarrays produced by the Frederick Cancer Research and Development Center
Microarray Core (Desai et al., 2002) . Array features have gone through a quality screen process, and the lowess fit (Yang et al., 2002) to the log-ratios of intensities from the two channels vs. the average of log-intensities for each microarray was close to a horizontal line and thus the median normalization was applied to each array. Only array elements without any flagged spots were included in the analysis, yielding 7421 genes, and the log base 2 ratios of the intensities were used in the analysis.
The correlation coefficients between the 5 individual samples range from .89 to .95 and the correlations between the three repeated arrays are all close to .96, indicating the array variance is small relative to the biological variance. The total variance τ 2 + σ 2 for each gene was estimated by the sample variance of the expression measurements from the 5 individual samples, and the array variance σ 2 was estimated from the three repeated arrays. The median total variance and array variance are .051 and .022 respectively. The biological variances were estimated by taking the difference between estimates of the total variance and array variance. About 25% of the variance ratio estimates are negative, likely due to the instability of the small-sample variance and genes with small biological variation.
Excluding the genes with the negative values, the median of the variance ratio λ is equal to 3.1. Since the pooled sample contains RNA from the mixed RNA of the five equally contributed individual samples, based on model (1) and (4), the average expression of the five individual samples and the average expression of the three repeats of the pool sample contain the same biological measures, and thus their difference subtracts out the biological variation and is associated with the array variation only. Under (1) and (4), the mean and standard error of the difference is equal to 0 andσ 1/5 + 1/3 respectively, and the standardized difference (difference/standard error) follows a t-distribution with 2 degrees of freedom ( = degrees of freedom ofσ 2 ). The plot of the difference vs. the average logratio of the five individual samples across all the genes is provided in the supplementary material. Although the correlation between the two sets of mean expression measurements is as high as 0.97, 233 spots are outside the 99% confidence limits, about three times as many as would be expected if model (4) is correct, and 35% of them have the absolute difference greater than .5. To further study if the bias introduced by pooling is associated with the magnitude of the signals, the proportion of spots with the difference outside the 99% confidence interval was calculated for each subgroup of spots with similar intensities.
Specifically, the normalized log-intensities of the 5 individual mouse mammary samples from the red channel (= normalized log-ratio + log-intensity from the green channel) were averaged and grouped into the following intervals: < 7, 7 − 8, · · · , 12 − 13, and ≥ 13, and the proportion of spots outside the 99% confidence intervals was calculated for each interval. Figure 1 plots the proportion against the median of log-intensities in each interval.
It exhibits an increasing trend of the proportion with the increasing intensities, indicating that the pooling bias tends to affect strong signals.
[Insert Figure 1 about here]
The second experiment generated gene expression measurements from 9 arrays using the Affymetrix U74-A version 2 chips. Of the 9 arrays six used RNA from normal mouse mammary gland at 12 week old from the FVB/NJ strain virgin mice, and the remaining three were repeated arrays using the pooled RNA by mixing an equal amount of RNA from the six individual mammary samples. Total RNA was extracted from frozen tissue using TRIzol Reagent (Life Technologies, Inc., Rockville, MD) according to the manufacturer's protocol.
10 g each of total RNA was reverse transcribed using a T7 (dT)24 primer to synthesize the complementary DNA, followed by the incorporation of biotinylated ribonuceotides by in vitro transcription using T7 RNA polymerase. The biotynylated-labeled RNA was purified, fragmented and hybridized to an ologonucleotide microarray Murine Genome U74Av2 chip containing 12,488 features (Affymetrix, Santa Clara, CA) according to the manufacturer's recommendations. RNA for the three repeats were labelled and purified separately, and then hybridized in the same condition.
Using the log-transformed MAS 5.0 summary measures, the correlation coefficients between the 6 individual samples range from .72 to .96, and one sample appears to show lower correlation with the rest of the samples. The median total variance and array variance are .43 and .07 respectively, and about 18% of the estimates of the biological variance were negative. Excluding the genes with the negative values, the median of the variance ratio λ is equal to 6.4, implying that the array data for a majority of the probe sets express well the biological variability with small measurement errors. The standard error of the difference of the average expression of the 6 individual samples and the average expression of the three repeats of the pool sample is equal toσ 1/6 + 1/3. The plot of the difference vs.
the average expression of the 6 individual samples appears in the supplementary material.
Although the correlation between the two sets of mean expression measurements is also high (0.92), out of the total of 12488 probe sets, 1517 with the difference fall outside the 99% confidence intervals, a number far more than expected by chance, and the majority of them (> 89%) have the absolute differences greater than .5. Figure 2 plots the proportion of probe sets with the difference outside the 99% confidence limits against the median log-signal in each of the following intervals: < 3, 3 − 4, 4 − 5, ..., 11 − 12, ≥ 12. It shows a clear and stronger trend than observed in the cDNA data that the proportion increases monotonically with the signal. The recently proposed expression measures RMA (Irizarry et al., 2003) and GC-RMA (Wu et al., 2004) were also calculated. These expression measures give similar but worse results: 3037 and 2338 probe sets fall outside the 99% confidence intervals respectively. Graphical presentations of the analysis results using RMA and GCRMA are given in the supplementary material. Thus this Affymetrix experiment shows that the major pooling assumption also may not hold, and the pooling bias appears severer than for the cDNA array and tends to occur when the signal is strong.
[Insert Figure 2 about here]
DISCUSSION
In this paper, we study the effects of pooling mRNA in detecting differential gene expression. We present formulas for the required number of subjects and arrays for a pooled design to achieve the same power as in an non-pooled experiment. It demonstrates that the benefit of pooling with respect to power depends on both the ratio of the biological to array variation and the degrees of freedom. If the number of independent sets of pools is reasonably large and the variance ratio is high, then the pooled design with a smaller number of arrays could achieve a power comparable to the non-pooled design without an excessive increase of the number of subjects. However, if the number of pools is small, then the loss of power due to small degrees of freedom may not be recovered even with a large increase of the number of subjects.
The cost implication from a pooled design depends on the cost per subject and the cost per array, and must be assessed on a case-by-case basis. Generally, a pooled design does not necessarily guarantee the saving of cost unless the subject cost is low relative to the array cost. For a transgenic mice array experiment that we have encountered, we estimate that the cost for a transgenic mouse and associated housing and labor is $230 and the cost for an array chip and reagent is $300. Under the non-pooled design, the total cost for the experiment with 11 transgenic mice is (230 + 300) × 11 = 5830. Following the first scenario considered in the Section of Comparisons, assuming λ = 4, with 8 arrays 21 subjects are required to achieve the comparable 95% power (see Table 1 ). Thus, the total cost for the pooled experiment is 230 × 21 + 300 × 8 = 7230. Alternatively if one considers 10 arrays and 13 subjects, then the associated cost is 5990. In either case, the non-pooled design is more cost-effective. Thus, if there is enough RNA from each individual mouse to run an array, the non-pooled design is recommended. Otherwise, one needs to determine the minimal required number of subjects for pooling and estimate the number of pools and the total cost accordingly. For example, if 3 subjects are required for each pool, according to Table 2 , one needs to have 8 pools yielding the total cost of 230 × 3 × 8 + 300 × 8 = 7920.
The major assumption of pooling is that the expression from a pooled sample averages out the expression from the individual contributing samples. We checked this assumption from both the cDNA and Affymetrix array experiments. The analysis results show that this assumption may not hold especially when the signals are strong, because in both experiments the number of genes with significant differences between the average expression measurements of the individual contributing samples and the average expression measurements of the repeats of the pooled sample is larger than would be expected by chance.
Compared to the cDNA arrays, the pooling bias appears to be severer for the Affymetrix arrays. Since the equal amount of RNA was used for each individual sample, a possible reason for the bias is that mixing of the RNA may cause some alteration of individual RNA contributions such that some samples dominate more than the others in the pooled expression. Finally, in addition to the potential bias of the expression measurements from pooling, another disadvantage is that one may not be able to associate the gene expression from the pooled sample with the individual phenotypic information, and thus can not make certain statistical inference or predictions for individuals. In view of these potential disadvantages with pooling, one has to be cautious about designing a pooled experiment.
Generally, pooling of samples is recommended when there is not enough RNA from each individual sample to run an array. In this case, the number of different pools should not be too small and the number of subjects should be appropriately increased to compensate for the loss of degrees of freedom and decrease in power caused by pooling samples. Table 1 : Lower bound of the required number of subjects with respect to the number of pools (n p ) and the ratio of biological to array variance (λ)
Number of subjects using Number of subjects using (6 1 The number of subjects required for the pooled design to achieve the targeted 95% power in detecting a 2-fold mean difference between the two classes at the .001 significance level.
2 The number of subjects required for the pooled design to achieve the same efficiency in terms of the variance of squared length of the 95% confidence interval as the non-pooled design. Table 2 : Number of pools required to achieve 95% power with respect to r, λ and ν 
